MRSA鼻腔筛查在抗菌药物管理中的效用评估
结果显示总体阴性预测值为96.5%,不同部位培养的阴性预测值在93.1%至99.2%之间,提示高阴性预测值可作为抗菌药物降阶梯和避免经验性抗MRSA治疗的管理工具。
要点
- MRSA鼻腔筛查阴性对后续MRSA临床培养阳性的阴性预测值达96.5%。
- 尿培养的阴性预测值最高为99.2%,伤口培养最低为93.1%。
- 高阴性预测值支持将鼻腔筛查用于避免经验性抗MRSA治疗。
核心结论
- MRSA鼻腔筛查具有高阴性预测值,可作为抗菌药物降阶梯和避免经验性抗MRSA治疗的有力管理工具。
主要发现
- MRSA鼻腔筛查预测临床培养阳性的敏感度为67.4%,特异度为81.2%。
- 总体阴性预测值为96.5%,血流感染为96.5%,腹腔内培养为98.6%,呼吸道培养为96.1%,伤口培养为93.1%,泌尿系统培养为99.2%。
关键数值与推荐
- MRSA鼻腔筛查阴性排除MRSA感染的阴性预测值为96.5%。
- 不同培养部位阴性预测值:血流96.5%、腹腔内98.6%、呼吸道96.1%、伤口93.1%、泌尿系统99.2%。
- 敏感度67.4%,特异度81.2%。
临床怎么用
- 可利用MRSA鼻腔筛查的高阴性预测值,对筛查阴性患者避免经验性抗MRSA治疗或进行降阶梯治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Treatment of suspected methicillin-resistant Staphylococcus aureus (MRSA) is a cornerstone of many antibiotic regimens; however, there is associated toxicity. The Department of Veterans Affairs (VA) hospitals screen each patient for MRSA nares colonization on admission and transfer. The objective was to determine the negative predictive value (NPV) of MRSA screening in the determination of subsequent positive clinical culture for MRSA. High NPVs with MRSA nares screening may be used as a stewardship tool. METHODS: This was a retrospective cohort study across VA medical centers nationwide from 1 January 2007 to 1 January 2018. Data from patients with MRSA nares screening were obtained from the VA Corporate Data Warehouse. Subsequent clinical cultures within 7 days of the nares swab were evaluated for the presence of MRSA. Sensitivity, specificity, positive predictive values, and NPVs were calculated for the entire cohort as well as subgroups for specific culture sites. RESULTS: This cohort yielded 561 325 clinical cultures from a variety of anatomical sites. The sensitivity and specificity for positive MRSA clinical culture were 67.4% and 81.2%, respectively. The NPV of MRSA nares screening for ruling out MRSA infection was 96.5%. The NPV for bloodstream infections was 96.5%, for intraabdominal cultures it was 98.6%, for respiratory cultures it was 96.1%, for wound cultures it was 93.1%, and for cultures from the urinary system it was 99.2%. CONCLUSION: Given the high NPVs, MRSA nares screening may be a powerful stewardship tool for deescalation and avoidance of empirical anti-MRSA therapy.
引用
- Mergenhagen KA, Starr KE, Wattengel BA, et al. Determining the Utility of Methicillin-Resistant Staphylococcus aureus Nares Screening in Antimicrobial Stewardship. Clin Infect Dis. 2020. PMID: 31573026. doi:10.1093/cid/ciz974
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。